(177)Lu-PSMA-617 radioligand therapy for a patient with lymph node metastatic prostate cancer

Prostate specific membrane antigen (PSMA) is expressed in unfavorable prostate cancer. PSMA is basis for new diagnostics and theranostics. PET/CT using PSMA is more sensitive than choline PET/CT. (177)Lu-PSMA radioligand therapy is mainly used for patients with end-stage prostate cancer. This report...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncotarget
Main Authors: von Eyben, Finn E., Kiljunen, Timo, Joensuu, Timo, Kairemo, Kalevi, Uprimny, Christian, Virgolini, Irene
Format: Artigo
Sprog:Inglês
Udgivet: Impact Journals LLC 2017
Fag:
Research Paper
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5630396/
https://ncbi.nlm.nih.gov/pubmed/29029496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19805
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker